Max von Arnim

Max von Arnim has a diverse work experience in various companies. Max began their career in 2012 as an intern at SEMPORA Consulting GmbH. In 2014, they worked as a Business Development Intern at Valendo GmbH and also participated in the Assistant AuditPLUS Program at EY. In 2015, they had a short-term role as an Assistant AuditPLUS Program in Mexico. From 2018 to 2020, Max served as a Senior Consultant in Transaction Advisory Services at EY. Max then joined KonfiDents GmbH in 2020 as an M&A and Business Development professional until 2021. Currently, Max is employed at Patient21, where they continue to work in M&A and Business Development.

Max von Arnim began their education at Friedrich-Dessauer-Gymnasium from 2009 to 2011, obtaining their Abitur degree. Max then pursued their undergraduate studies at EBS Universität für Wirtschaft und Recht from 2011 to 2014, earning a Bachelor of Science degree in General Management. In 2013, they also completed a semester abroad at Pontificia Universidad Católica de Chile. Max later attended Rotterdam School of Management, Erasmus University, where they obtained a Master of Science degree in Finance and Investments from 2016 to 2017. Additionally, they participated in an exchange program at UNC Kenan-Flagler Business School in 2017, completing coursework towards a Master of Business Administration degree. Max has also obtained certifications, such as the GMAT from the Graduate Management Admission Council® in August 2013, and Bloomberg Market Concepts from Bloomberg LP. In 2008, they were an exchange student at Escuela Cristobal Colon in Mexico City, Mexico, although no degree was specified for this experience.